Iradimed (IRMD) Revenue (2013 - 2026)

Iradimed (IRMD) has reported Revenue for 14 consecutive years, with $20.5 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Revenue changed 0.28% year-over-year to $20.5 million in Q2 2026; TTM through Jun 2026 was $86.3 million, a 11.21% increase from a year earlier, with the FY2025 full-year figure at $83.8 million, up 14.43% from the prior year.
• Revenue was $20.5 million for Q2 2026 at Iradimed, down from $22.0 million in the prior quarter.
• Over five years, Revenue peaked at $22.7 million in Q4 2025 and troughed at $12.3 million in Q1 2022.
• A 5-year average of $17.7 million and a median of $17.8 million in 2024 frame the typical range for Revenue.
• Across the five-year window, Revenue soared 33.46% in 2022 and increased 0.28% in 2026, its largest moves.
• Over 5 years, Revenue stood at $14.9 million in 2022, then increased by 17.42% to $17.5 million in 2023, then increased by 11.1% to $19.4 million in 2024, then rose by 17.03% to $22.7 million in 2025, then decreased by 9.81% to $20.5 million in 2026.
• The last three Revenue figures came in at $20.5 million (Q2 2026), $22.0 million (Q1 2026), and $22.7 million (Q4 2025), per Business Quant data.